- Home
- IMNN vs CSCI Comparison
IMNN vs CSCI Comparison
Compare IMNN & CSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- CSCI
- Stock Information
- Founded
- IMNN 1982
- CSCI 1990
- Country
- IMNN United States
- CSCI Canada
- Employees
- IMNN N/A
- CSCI N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- CSCI
- Sector
- IMNN Health Care
- CSCI
- Exchange
- IMNN Nasdaq
- CSCI NYSE
- Market Cap
- IMNN 12.1M
- CSCI 9.9M
- IPO Year
- IMNN 1985
- CSCI 1996
- Fundamental
- Price
- IMNN $0.60
- CSCI $3.34
- Analyst Decision
- IMNN Strong Buy
- CSCI
- Analyst Count
- IMNN 2
- CSCI 0
- Target Price
- IMNN $15.50
- CSCI N/A
- AVG Volume (30 Days)
- IMNN 237.6K
- CSCI 4.3K
- Earning Date
- IMNN 05-12-2025
- CSCI 05-13-2025
- Dividend Yield
- IMNN N/A
- CSCI N/A
- EPS Growth
- IMNN N/A
- CSCI N/A
- EPS
- IMNN N/A
- CSCI N/A
- Revenue
- IMNN N/A
- CSCI $9,030,000.00
- Revenue This Year
- IMNN N/A
- CSCI N/A
- Revenue Next Year
- IMNN N/A
- CSCI N/A
- P/E Ratio
- IMNN N/A
- CSCI N/A
- Revenue Growth
- IMNN N/A
- CSCI 127.46
- 52 Week Low
- IMNN $0.64
- CSCI $1.96
- 52 Week High
- IMNN $3.65
- CSCI $11.10
- Technical
- Relative Strength Index (RSI)
- IMNN 24.71
- CSCI N/A
- Support Level
- IMNN $0.60
- CSCI N/A
- Resistance Level
- IMNN $1.08
- CSCI N/A
- Average True Range (ATR)
- IMNN 0.08
- CSCI 0.00
- MACD
- IMNN -0.02
- CSCI 0.00
- Stochastic Oscillator
- IMNN 3.12
- CSCI 0.00
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology. The Company has two reportable and operating segments: Active ingredient and Biopharmaceutical.